Bone therapy is a broad term covering any medical treatment designed to strengthen bones, prevent bone loss, or repair bone damage. It most commonly refers to medications for osteoporosis, but it also includes treatments that protect bones during cancer care, surgical procedures like bone grafting, and exercise-based approaches that stimulate bone growth. The specific type of bone therapy a person needs depends on whether the goal is slowing bone breakdown, building new bone, or replacing damaged bone tissue.
How Bone Loss Happens
Your skeleton is constantly being remodeled. Specialized cells called osteoclasts break down old bone, while osteoblasts build new bone to replace it. In healthy adults, this process stays roughly in balance. But certain conditions tip the scale toward more breakdown than building: aging, hormonal changes (especially after menopause), long-term use of certain medications like corticosteroids, and diseases such as hyperthyroidism or rheumatoid arthritis.
A bone density scan measures how much mineral your bones contain and expresses the result as a T-score. A score of negative 1 or higher is healthy. Between negative 1 and negative 2.5 indicates osteopenia, a milder form of bone loss. A score at or below negative 2.5 typically means osteoporosis. These numbers guide which type of bone therapy, if any, your doctor recommends.
Antiresorptive Therapy: Slowing Bone Breakdown
The most widely prescribed bone therapies are antiresorptive drugs, which work by slowing the cells that break down bone. With less bone being removed, the skeleton has more time to fill in and mineralize, gradually increasing density. Two main categories dominate this space.
Bisphosphonates are the most commonly prescribed option. They bind directly to bone tissue and, once absorbed by bone-breaking cells, either inactivate or kill those cells. Dosing varies: some are taken as a weekly or monthly pill, while one form is given as an intravenous infusion once a year. Because bisphosphonates remain embedded in bone long after you stop taking them, doctors often consider a “drug holiday” after several years. For people at moderate fracture risk, a break is typically discussed after 5 to 10 years of treatment. For those at lower risk, a pause may come after 3 to 5 years. People with a history of fractures or very low bone density may continue for up to 10 years before a break is considered.
The other major antiresorptive is a biologic injection given under the skin every six months. It works differently, blocking a specific protein that osteoclasts need to develop and survive. It tends to produce slightly greater gains in bone density than bisphosphonates, but unlike bisphosphonates, its effects wear off quickly once you stop, so continuous treatment or a transition to another therapy is important.
Anabolic Therapy: Building New Bone
While antiresorptive drugs slow bone loss, anabolic therapies actively stimulate new bone formation. This distinction matters because antiresorptive drugs can’t rebuild bone structure that has already deteriorated. Anabolic agents can at least partially restore the internal architecture of bone, which independently affects fracture risk beyond what density numbers alone capture.
These treatments are typically reserved for people at high fracture risk. One type, a daily injection, mimics a natural hormone involved in calcium regulation and bone turnover. It’s approved for use up to 24 months. Another option targets a protein that normally acts as a brake on bone formation; by blocking that brake, it lets osteoblasts work harder. This one is given as a monthly injection for up to 12 months.
A key detail about anabolic therapy: the bone-building effect is self-limiting. Once the treatment window ends, you need to transition to an antiresorptive drug to lock in the gains. Skipping that follow-up step can result in rapid loss of the new bone you just built.
Bone Therapy in Cancer Care
When cancer spreads to the skeleton, it disrupts the normal balance of bone remodeling. Tumors can trigger excessive bone breakdown, leading to fractures, severe pain, and dangerously high calcium levels in the blood. Both bisphosphonates and the biologic injection used for osteoporosis play a role here, though often at higher doses or different schedules.
In breast cancer specifically, bone-targeted therapy has become part of routine care. Cancer treatments like aromatase inhibitors and certain hormone-suppressing drugs can themselves cause significant bone loss, creating a need for bone protection even before metastases develop. Clinical guidelines now recommend that postmenopausal women with early breast cancer who face meaningful recurrence risk receive adjuvant bisphosphonate therapy. This serves a dual purpose: protecting against treatment-induced osteoporosis and potentially reducing the risk of cancer spreading to bone in the first place.
In multiple myeloma, a blood cancer that originates in the bone marrow, bone-targeted agents appear to do more than just protect the skeleton. Evidence suggests they may also extend the time before the disease progresses.
Bone Grafting and Surgical Repair
When bone is damaged beyond what the body can heal on its own, such as a large fracture gap, a failed healing attempt (called a nonunion), or bone destroyed by infection, surgical bone therapy becomes necessary. The goal is to provide a scaffold or biological stimulus for new bone to grow.
Grafts from your own body are considered the gold standard. Surgeons most commonly harvest spongy bone from the hip, which is rich in cells and growth factors that promote healing. When structural support is the priority, denser cortical bone is used instead. For large defects, a living piece of bone with its blood supply still attached can be transplanted from another part of the body, most often the fibula (the smaller bone in the lower leg).
Donor bone from a tissue bank is another option. It provides structural support but lacks living cells, so it heals more slowly. It’s frequently used in spinal fusion procedures and to stabilize fractures around joint replacements. Processed forms of donor bone, with the mineral content removed, can also serve as a filler for bone defects and are popular as supplements to spinal fusions.
Synthetic bone substitutes made from calcium-based materials offer a third path. They act as a framework for the body’s own bone to grow into. One advantage is that they can be mixed with antibiotics, making them especially useful when infection is part of the problem.
Exercise as Bone Therapy
Physical activity is one of the most accessible forms of bone therapy, and its mechanism is straightforward. Bone adapts to the loads placed on it. This principle, known as Wolff’s Law, means that when you consistently subject your skeleton to forces greater than everyday walking and sitting, your bones respond by becoming denser and stronger.
Weight-bearing exercise is any activity that generates a load on a skeletal region beyond what normal daily life demands. The most effective types involve impact or resistance: jogging, jumping rope, tennis, martial arts, gymnastics, drop jumps, lunges, sprints, and hopping drills. Activities like swimming and cycling, while excellent for cardiovascular health, don’t generate the mechanical loading bones need to remodel.
For people already on medication for osteoporosis, exercise works alongside drug therapy rather than replacing it. The combination of pharmacological treatment and consistent weight-bearing activity produces better outcomes than either approach alone.
Calcium and Vitamin D: The Foundation
No bone therapy works well without adequate raw materials. Calcium provides the mineral content of bone, and vitamin D is essential for absorbing calcium from food. Recommended daily calcium intake is 1,000 milligrams for adults aged 19 to 50, rising to 1,300 milligrams for adolescents. Vitamin D recommendations sit at 600 IU per day for anyone over age 1. Many adults, particularly those with limited sun exposure or darker skin, fall short on vitamin D without supplementation.
These aren’t treatments in themselves for established osteoporosis, but they’re considered a baseline requirement. Starting a bisphosphonate or anabolic therapy without ensuring adequate calcium and vitamin D intake undermines the treatment’s effectiveness.
Bone Therapy vs. Bone Marrow Transplant
One common point of confusion: bone therapy is not the same as a bone marrow transplant. A bone marrow transplant (also called a stem cell transplant) replaces diseased marrow, the spongy tissue inside bones that produces blood cells, with healthy stem cells. It’s used for blood cancers like leukemia and lymphoma, certain immune disorders, and bone marrow failure. The procedure treats the blood-forming system, not the bones themselves, even though the marrow lives inside them.